What happens to our healthcare needs and costs
Its typically offered in vials that you draw up yourself with a syringe, rather than pre-filled pens
I often explain to my patients that GLP-1s turn down the volume on hunger signals, making healthy choices easier
In October, Eli Lillys Zepbound and Mounjaro were removed from the drug shortage list after nearly two years, though the FDA warned that there still may be intermittent localized supply disruptions. The removal from the listwhich bars outsourcing facilities from producing compounded versionsspurred the Outsourcing Facilities Association to file a lawsuit against the FDA, saying the move will deprive much of the public of access to a needed medicine. In response, the FDA agreed to reevaluate the situation and will allow compounding to continue during this period
(2024) Lipid profile changes induced by glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a systematic review and network meta-analysis
McLeod DSA, Caturegli P, Cooper DS, et al
